NCT01408121View on ClinicalTrials.gov

African-American Pharmacogenetics

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Acute Coronary Syndrome
Interventions
OTHER

Genotyping and platelet reactivity testing with the VerifyNow P2Y12 assay

All patients will undergo genotyping and platelet reactivity testing with the VerifyNow P2Y12 assay, at least 6 hours after receiving a thienopyridine loading dose but before hospital discharge.

Trial Locations (1)

20010

Washington Hospital Center, Washington D.C.

Sponsors
All Listed Sponsors
lead

Medstar Health Research Institute

OTHER